Abstract
The presence of apoptotic bodies and of intraepithelial lymphocytes (IELs) were assessed in colorectal adenomas and adenocarcinomas induced in 158 rats by two different carcinogens: 1,2 dimethylhydrazine (DMH) and glutamic acid pyrolysate (GLU-P-1 and 2). Apoptotic granules were present in 97.5% ( n=40) of the 41 GLU-induced adenomas and adenocarcinomas, but only in 20.5% ( n=24) of the 117 DMH-induced tumours. IELs were found in 95.1% ( n=39) of the 41 GLU-induced tumours but only in 21.4% (n=25) of the 117 DMH-induced neoplasias. The differences were significant ( p< 0.001). The presence of IELs and apoptotic granules in GLU tumours (and their absence in the majority of the DMH tumours) is new evidence that IELs are the cells from which many of the apoptotic granules — seen in colorectal neoplasias — derive. GLU neoplasias were induced following daily treatment, for 24 months (about half the life span of the animals) and DMH neoplasias by weekly doses, for a period of only 2.8-6 months. It would appear that 'slowly growing' colorectal GLU neoplasias often attract IELs and trigger lymphocytic apoptosis whereas 'quickly growing' DMH tumours seldom evoke those reactions.
Similar content being viewed by others
References
Leuchtenberger C. Cytoplasmic ‘inclusion bodies’ containing desoxyribose nucleic acid (DNA) in cells of human rectal polyps. Lab Invest 1954; 3: 132-142.
Leuchtenberger C, Leuchtenberger R, Lieb E. Studies of the cytoplasmic inclusions containing deoxyribose nucleic acid (DNA) in human rectal polypoid tumours including familial hereditary type. Acta Genet 1956; 6: 291-297.
Helwig F. Cytoplasmic inclusion bodies in chronic ulcerative colitis: their relationship to polyps and cancer. Dis Colon Rectum 1958; 1: 270-275.
Helwig F. Epithelial cytoplasmic inclusion bodies of possible virus origin in clinically early ulcerative colitis. Dis Colon Rectum 1959; 2: 23-26.
Fisher ER, Sharkey DA. The ultrastructure of colonic polyps and cancer with special reference to the epithelial inclusion bodies of Leuchtenberger. Cancer 1962; 15: 160-170.
Walb D, Sandritter W. Inclusion bodies in rectal polyps. Arch Pathol 1964; 78: 104-107.
Kerr JFR. A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes. J Pathol Bacteriol 1965; 90: 419-435.
Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
Rubio CA, Kumagai J, Kanamori T, Nakamura K. Apoptosis in flat neoplasias of the colorectal mucosa. In Vivo 1995; 9: 173-176.
Rubio CA, Kato Y, Hirota T. Intraepithelial lymphocytes in flat colorectal adenomas. In Vivo 1997; 11: 324-325.
Rubio CA, Takayama S. Difference in histology and size in colonic tumors of rats receiving two different carcinogens. J Env Pathol Toxicol Oncol 114; 13: 191-197.
Rubio CA, Shetye J. Flat adenoma-adenocarcinoma sequence in the colon of rats. Dis Colon Rectum 1994; 37: 1300-1306.
Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642.
Rubio CA, Alm T, Aly A, Poppen B. Intraepithelial bodies in colorectal adenomas: Leuchtenberger bodies revisited. Dis Colon Rectum 1991; 34: 47-50.
Rubio CA, Jakobsson B, Cataños-Velez E, Lindblom A, Jaramillo E, Slezak P. Cytotoxic intraepithelial lymphocytes in colorectal polyps. Gastroenterology (submitted)
Merogi AJ, Marrogi AJ, Ramesh R, Robinsson WR, Fermin CD, Freeman SM. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Hum Pathol 1997; vn 28: 321-330.
Rubio CA. Intraepithelial lymphocytes versus colorectal neoplastic cells: who is winning the apoptotic battle? Apoptosis 1997; 2: 489-493.
Hahne M, Rimoldi D, Scröter M, et al. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996; 274: 1363-1366.
Seino KI, Kayagaki N, Okumura K, Yagita H. Antitumor effect of locally produced CD95 ligand. Nature Med 1997; 3: 165-172.
Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion? Nature Med 1996; 2: 1361-1366.
Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas-ligand apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-1192.
O'Connell J, O'sullivan GC, Collins JK. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996; 184: 1075-1082.
Rubio CA. Tumor cells induce apoptosis in lymphocytes. Nature Med 1997; 3: 253-254.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubio, C.A. Apoptotic differences in experimentally induced colorectal rat tumours. Apoptosis 3, 35–39 (1998). https://doi.org/10.1023/A:1009607102797
Issue Date:
DOI: https://doi.org/10.1023/A:1009607102797